The largest database of trusted experimental protocols

33 protocols using lsrii analyser

1

Mitochondrial Membrane Potential Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty‐four hours after transfection and preceding CCCP treatment, cells were loaded with Rhodamine 123 (0.05 mg/ml, 15 min). Following treatment, the cells were collected for fluorescence‐activated cell sorting (FACS) on the BD LSR II Analyser, with excitation and emission settings of 488 and 530 nm, respectively. Thirty thousand events were recorded per sample, and the geometric mean of the fluorescence intensity values was analysed.
+ Open protocol
+ Expand
2

Isolation and Characterization of Adipose-Derived Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Precursor isolation is described in [18] . Briefly, stromal-vascular fraction (SVF) was prepared from each fat pad by collagenase treatment. Cells were then pelleted by centrifugation, cleared, and suspended in staining media (HBSS + 2% FBS), and labeled with appropriate antibodies (Supplementary Table 2). After staining, cells were filtered through a 35-μm cell-strainer capped tube to ensure single cell suspension and stained with live/dead Blue. Live single cells were gated according to the expression of surface markers (CD31-CD45-CD29 + CD34 + Sca1+) in a BD LSRII analyser. Data were analyzed with FlowJo.
+ Open protocol
+ Expand
3

Cytokine Analysis of CD4+ T-cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T-cells were isolated from total PBMCs by negative selection using EasySep Human CD4 T Enrichment columns (StemCell, Cat #19052). Purity of CD4 was typically >98% as determined by surface staining of CD4+ T-cells with CD3-Pacific Blue (UCHT1) and CD4-Alexa Fluor 700 (RPA-T4), (both from BD) and FACS analysis (BD LSRII analyser). Purified CD4+ T-cells were stimulated with plate-coated anti-CD3 antibody (0.5μg/ml) and soluble anti-CD28 antibody (0.5μg/ml) (both from BD Biosciences, Cat ##555329, 5555726 respectively) for 48 h in the presence or absence of 500 ng IL-32α (BioLegend, Cat # 551004) or IL-32γ (R&D Cat # 4690-IL-025/CF). Secreted cytokines were measured from the supernatant of activated cells using the LEGENDplex™ Human Th Cytokine Panel (13-plex) (BioLegend, Cat # 740001) according to manufacturer’s directions. Infections of PBMCs stimulated with PHA and IL-2 (0.25μg/ml, and 100 units/ml, respectively) or resting cells were carried out using 50 ng of the laboratory strain HIV-BaL per 106 cells by Spinoculation61 (link) (2 hours/Room temperature). Following infection, PBMCs were washed twice by PBS and centrifuged at 1500 rpm for 5 min then were re-suspended in RPMI-1640 medium supplemented with 10% FBS. Cells were kept in culture for 48 h before collection of supernatants and cells for cytokine measures.
+ Open protocol
+ Expand
4

Endothelial Cells Transduction by RBC-AAV

Check if the same lab product or an alternative is used in the 5 most similar protocols
EA.hy926 human endothelial cells were seeded in a 6‐well plate at 200 000 cells/well, and incubated overnight prior to treatment. Cells were treated for 14 days with an equivalent dose of either free AAV‐eGFP or AAV‐eGFP recovered from RBC‐AAV‐eGFP by lysing RBCs at different AAV to endothelial ratios. eGFP expression in transduced cells was both visualized with fluorescence microscopy and quantified with flow cytometer (BD LSR II Analyser).
+ Open protocol
+ Expand
5

Multiparametric Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Different panels of antibody cocktails were generated from anti‐CD45 (BioLegend, 103116, 30‐F11), anti‐CD3 (BioLegend, 100218, 17A2), anti‐CD4 (BioLegend, 100421, GK1x.5), anti‐CD8a (BioLegend, 100711, 53‐6.7), anti‐NKp46 (BioLegend, 137606, 29A1.4), anti‐CD11c (BioLegend, 117307, N418), anti‐CD25 (Biolegend, 101908, 3C7), anti‐FOXP3 (Biolegend, 126404, MF‐14), anti‐granzyme B (BioLegend, 372208, QA16A02), anti‐IFNγ (BioLegend, 505849, XMG1.2), anti‐IFNγ (BioLegend, 505806, XMG1.2, anti‐CD62L (BioLegend, 104432, MEL‐14) and anti‐CD44 (BD Biosciences, 560568, IM7) antibodies, and the AmCyan Live/Dead Cell Staining Kit (Thermo Fisher Scientific). All antibodies were diluted at optimized dilutions before being used.
Female 7–8 weeks old C57BL/6 mice (n = 4–5 per group) were intravenously administered with the equivalent dose (3.8 × 1010 vg/mouse) of either free AAV‐fLuc or RBC‐AAV‐fLuc. Mice were then euthanized on day 31, and spleen and lungs were collected. Organ dissociation kits (Miltenyi Biotec) were used per manufacturer's instruction to generate a single‐cell suspension from excised organs, and cells were stained with the antibodies listed above and analyzed using flow cytometry (BD LSR II Analyser). Flow cytometry data analyses were performed using FlowJo 10 software.
+ Open protocol
+ Expand
6

Tracking T Cell Responses to BMDC Transplant

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thy1.1+/1.2+ P14 T cells and Thy1.1+/1.1+ SMARTA T cells were isolated from TCR Tg mice as detailed above. 105 P14 T cells and 105 SMARTA T cells were co-transferred I.V. by retro-orbital injection into wild-type B6 recipients 0–19 days prior to BMDC transplant.
BMDCs were prepared from the bone marrow of NINJA mice as described in47 (link). Four days after bone marrow harvest, maturing BMDCs were transduced in vitro with 1010 PFU/mL of recombinant Ad5CMVFLPo (Iowa Vector Core, VVC-U of Iowa-530HT) or 3.5 × 108 PFU/mL of recombinant Ad5CMVeGFP (Iowa Vector Core, VVC-U of Iowa-4). BMDCs were harvested 3 days later and stained with antibodies specific for CD11c (clone N418, BioLegend) and MHC-I (H-2Kb, clone AF6–88.5.5.3, eBioscience) and analysed by flow cytometry on a BD LSRII analyser (BD Biosciences). 104 CD11c+MHC-I+GFP+ BMDCs were then transplanted into the footpad of B6 hosts in 15 μls PBS.
Recipient animals were euthanized 7 days after BMDC transplant to collect spleen and the draining LN (popliteal). Organs were processed as described in5 (link) and samples were stained with antibodies specific for Thy1.1 (clone OX-7, BioLegend), Thy1.2 (clone 30-H12, BioLegend), CD4 (clone GK1.5, BioLegend) and CD8 (clone 53–6.7, BioLegend). Cells were then analysed on a BD LSRII flow cytometer (BD Biosciences).
+ Open protocol
+ Expand
7

Isolation and Characterization of Adipose Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adipose progenitor cells (APC) were isolated as follows8 (link), 29 (link): Stromal-vascular fraction (SVF) was prepared from each fat pad by collagenase treatment and SVF pellets were resuspended in erythrocyte lyses buffer (0.15 M ClNH4, 0.01 M HCO3K in water). Cells were then pelleted by centrifugation, resuspended in staining media (HBSS + 2% FBS), and labeled with appropriate antibodies. After staining, cells were filtered through a 35-μm cell-strainer capped tube to ensure single cell suspension and stained with live/dead Blue. Live single cells were gated according to the expression of surface markers (CD31CD45CD29+CD34+Sca1+) in a BD LSRII analyser. Data was analyzed with FlowJo.
+ Open protocol
+ Expand
8

HR assay in U2OS-DR-GFP cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HR assay was performed in U2OS-DR-GFP cell lines [37 (link),38 (link)]. Cells cultured in 6 well plates at 40% confluency were transfected twice with control or target siRNA. 24 hours after the second round of siRNA transfection, cells were transfected with I-SceI-expressing pCBASce plasmid. After an additional 48 hours of culture, cells were harvested and GFP positive cells were analyzed by flow cytometry (BD LSRII analyser).
+ Open protocol
+ Expand
9

Isolation and Characterization of Adipose Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adipose progenitor cells (APC) were isolated as follows8 (link), 29 (link): Stromal-vascular fraction (SVF) was prepared from each fat pad by collagenase treatment and SVF pellets were resuspended in erythrocyte lyses buffer (0.15 M ClNH4, 0.01 M HCO3K in water). Cells were then pelleted by centrifugation, resuspended in staining media (HBSS + 2% FBS), and labeled with appropriate antibodies. After staining, cells were filtered through a 35-μm cell-strainer capped tube to ensure single cell suspension and stained with live/dead Blue. Live single cells were gated according to the expression of surface markers (CD31CD45CD29+CD34+Sca1+) in a BD LSRII analyser. Data was analyzed with FlowJo.
+ Open protocol
+ Expand
10

Multiparametric Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions were treated with anti-CD16/32 (Fc block) (14-9161-73, ThermoFisher) and stained with the live/dead marker ethidium monoazide bromide (ThermoFisher #E1374) in 2% FBS in PBS. The following antibodies were used at a concentration of 1 μg/mL except where otherwise indicated: APC-Cy7-CD117 (clone 2B8; Biolegend #105826), PE-FceRI (clone MAR-1; eBioscience 12-5898-82), eFluor450-CD45 (clone 30-F11; eBioscience #48-0451-82), APC-CD11b (clone M1/70; ThermoFisher #17-0112-82), Alexa700-CD19 (clone 6D5; Biolegend #B189284), PE/Cy7-CD3e (clone 145-SC11, eBioscience #25-0031-82), APC-MHC II (clone M5/114.15.2, eBioscience #17-5321-82), and PE-Siglec F (clone E50-2440, BD Pharmingen #5521126). Cells were fixed with 1.6% paraformaldehyde (Electron Microscopy Sciences, #15710). Flow cytometry was performed using a BD LSRII analyser equipped with the following lasers: 355 nm (UV), 405 nm (violet), 488 nm (blue), and 633 nm (red). Data was analysed using FlowJo software. Gates were drawn according to fluorescence minus one (FMO) controls.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!